Evidence mapPaperPMID 39218890Full record

ArticleDiabetology & metabolic syndrome2024

Heterogeneous response of estimated insulin sensitivity indices to metformin in young individuals with type 1 diabetes and different phenotypes.

Luana A L Ramaldes, Sarah S Dos Santos, Patricia M Dualib, Joao R de Sa, Sérgio A Dib

Abstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luana A L RamaldesDepartment of Medicine, Division of Endocrinology, Diabetes Center, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Caixa Postal 20266 CEP 04022-001, Brazil. luanaramaldes@gmail.com.
Sarah S Dos SantosDepartment of Medicine, Division of Endocrinology, Diabetes Center, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Caixa Postal 20266 CEP 04022-001, Brazil.
Patricia M DualibDepartment of Medicine, Division of Endocrinology, Diabetes Center, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Caixa Postal 20266 CEP 04022-001, Brazil.
Joao R de SaDepartment of Medicine, Division of Endocrinology, Diabetes Center, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Caixa Postal 20266 CEP 04022-001, Brazil.
Sérgio A DibDepartment of Medicine, Division of Endocrinology, Diabetes Center, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Caixa Postal 20266 CEP 04022-001, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThis study aimed to investigate whether the response to adding metformin to insulin in young adults with type 1 diabetes (T1D) differs according to weight phenotype and insulin sensitivity index.

methodsA prospective pilot study was conducted over 26 weeks in which insulin plus metformin (2 g/day) was administered to 35 individuals, ranging from normal weight (NW) to overweight (OW) to obese (OB) T1D individuals, to correlate insulin sensitivity indices and other clinical variables.

resultsAt the end of the follow-up period, all groups showed an increase in the eGDR (NW: 7.37 vs 8.16, p = 0.002; OW: 7.28 vs 8.24, p < 0.001; OB: 6.33 vs 7.52 p < 0.001). K

conclusionsThe study showed that eGDR improved independently of basal weight after metformin treatment. However, the K

Indexed as

Insulin resistanceMetforminObesityType 1 diabetes mellitus

Identifiers

PMID39218890
PMCPMC11367792

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.